Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol with dexmedetomidine versus remifentanil for laryngeal mask airway insertion
ACTRN12625000184471Phase 4Completed
- Sponsor
- Firat University
- Start
- Jan 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, remifentanil and propofol (2 arms), sponsored by Firat University. Primary endpoints: LMA insertion conditions and Hemodynamic response. Started Jan 2014; status: completed.
02
Drugs
dexmedetomidineremifentanilpropofol
Beyond the preview
Go deeper on ACTRN12625000184471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000184471.